TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.

W Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.